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Abstract
Objective: The aim of this study was to review recent medical findings related to burnout, its diagnosis, treatment, charac-
teristic pathophysiological features, and preventive measures. Materials and Methods: A systematic review of the scientific 
literature in PubMed/Medline was performed. The most recent and important findings were reported. Results: Burnout 
was found to be a risk factor for myocardial infarction and coronary heart disease. It was also related to reduced fibrino-
lytic capacity, decreased capacity to cope with stress and hypothalamic-pituitary-adrenal (HPA) axis hypoactivity. Severe 
burnout symptoms are associated with a lower level or smaller increase of the cortisol awakening response (CAR), higher 
dehydroepiandrosterone-sulphate (DHEAS) levels, lower cortisol/DHEAS ratios and stronger suppression as measured by 
the dexamethasone suppression test (DST). More and more literature works suggest that the evaluation of the HPA axis 
should be brought to the attention of primary care physicians. There is no universal agreement on specific treatment and 
diagnostic measures to evaluate the wide range of HPA axis disorders. The cost-effective evaluation of adrenal hormones 
via saliva samples by a primary care physician may significantly alter the course of therapy in numerous chronic disease 
patients. Psychiatric disorders may have similar symptoms, but they have distinctive hormonal profiles. Having burnout 
recognized as a medical condition would help in differentiating burnout from similar clinical syndromes, such as depression 
or anxiety, and provide appropriate treatment to burnout patients. Proper treatment is essential for a fast and full recovery. 
Conclusion: Chronic stress-related disorders often fall outside the category of a “true” disease and are often treated as 
depression or not treated at all. The evaluation of adrenal hormones via saliva samples helps to predict burnout. Burnout 
screening techniques, dietary and nutritional guidelines and lifestyle changes for supporting the HPA function need to be 
developed. The presented material includes hormonal, dietary, and pharmaceutical perspectives.
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SUMMARY
Burnout can cause serious health implications; the current 
situation in burnout prevention and treatment could be 
improved. 
Burnout and depression have similar symptoms; burnout 
is often treated as depression or not treated at all.
The saliva cortisol test may help in predicting burnout and 
differentiating it from depression.
CONSIDERATIONS
Diagnosing a patient with burnout is problematic since 
burnout is not recognized as a mental illness and it is not 
listed in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM IV-TR, 2000). 
The use of antidepressants in burnout remains controversial.
There is no consensus about the diagnostic and treatment 
measures of burnout. 
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It has been shown to be a risk factor for myocardial infarc-
tion [4] and the coronary heart disease [1]. Vital exhaus-
tion (understood as burnout according to ICD-10-CM) is 
related to personality type D [5], which is defined as “ne­
gative affectivity and the tendency to inhibit the expres-
sion of this affect in social interaction”.
Vital exhaustion has also been related to reduced fibrino-
lytic capacity [6], hypothalamic-pituitary-adrenal (HPA) 
axis hypoactivity and decreased capacity to cope with 
stress [7]. Vital exhaustion was assessed by the Maastricht 
Questionnaire [4]. Subjects who scored in the upper third 
were labeled as exhausted and compared with those who 
scored in the lower or middle third. Nicolson and van Di-
est [8] found subtle HPA hypoactivity in vital exhaustion 
which might have been a result of chronic stress and asso-
ciated sleep disturbances. Researchers evaluated general 
cognitive ability, memory and attention in 67 female pa-
tients treated for chronic burnout [9]. The patients and 15 
healthy control subjects were tested with standardized 
tests of verbal and nonverbal cognitive ability (WAIS), 
verbal (Claeson­Dahl) and nonverbal (Rey complex figu­
res) memory, and visual and auditory attention (IVA). 
Significant reductions in nonverbal memory and auditory 
and visual attention were noted in the patient group. Re-
searchers suggest that explorations of possible neuroendo-
crine abnormalities as well as brain imaging may shed fur-
ther light on the pathophysiology and putative treatment 
regimes in this disorder. 
Esterling et al. [10] examined the long-term physiological 
consequences of chronic stressors, demonstrating that the 
physiological and psychological consequences of chronic 
stressors may persist well beyond the cessation of the ac-
tual stressor. 
There is no doubt that burnout has serious negative con-
sequences. However, it seems that current medical know-
ledge and practice are deficient in developing effective 
treatments for burnout. In this paper, we present the cur-
rent medical perspective on burnout.
INTRODUCTION
Burnout is specified by the International Classification of 
Diseases, 10th Revision, Clinical Modification (ICD­10­
CM) under “Factors influencing health status and con-
tact with health services (Z00-Z99)” as a “State of vital 
exhaustion” (Z73.0) and identified as a problem related 
to “life­management difficulty”. Vital exhaustion is de-
fined as a state characterized by lack of energy, increased 
irritabi lity, and demoralization [1]. Maslach [2] stated that 
burnout is a result of the prolonged response to chronic 
emotional and interpersonal stressors at the workplace, 
and it is defined by three dimensions of exhaustion, cyni-
cism, and inefficacy. The ICD­10­CM does not identify 
“vital exhaustion” as a separate diagnostic entity. A “State 
of vital exhaustion” is listed under the ICD-10-CM Diag-
nosis Code Z73.0 (burnout). Therefore, according to the 
ICD-10-CM, “vital exhaustion” refers to “burnout”. How-
ever, some researchers prefer using the term “burnout” 
when it is related to work overload and “vital exhaustion” 
when it is linked to family and financial stress [3]. Burnout 
is not a recognized disorder in the Diagnostic and Statisti-
cal Manual of Mental Disorders (DSM IV-TR, 2000). The 
lack of reference to burnout in the DSM IV-TR has impor-
tant implications. 
The presented material includes hormonal, dietary, 
and pharmaceutical perspectives. It is a call for more 
research and for developing new treatment approaches. 
Burnout adversely influences normal functioning. As 
for modern society illnesses, burnout cannot be traced 
back to one single cause. It is tied to a variety of risk 
factors. Feelings of inadequate control over one’s work, 
frustrated hopes and expectations, and low levels of 
satisfaction seem to be independent contributors to 
burnout. The burnout syndrome may be seen as a pro-
gressively-developed process resulting from the use of 
relatively ineffective coping strategies with which pro-
fessionals try to protect themselves from work-related 
stress.
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It is not uncommon for a family physician to mistake burn-
out for depression. As we will see, such a mistake may 
have devastating consequences for the patient. In clinical 
practice, it is important for a doctor to recognize burnout 
and distinguish it from disorders which may have similar 
symptoms (see Table 1).
An interview with a patient may result in considering the 
administration of a burnout questionnaire. There are 
a number of psychological scales for burnout available. The 
most popular is the Maslach Burnout Inventory (MBI) [11]. 
Using the MBI, it is possible to measure the level of cyni-
cism, exhaustion, and feelings of professional efficacy. 
Recognizing burnout
There are a number of important decisions to be made 
when a patient visits a family doctor to seek help. The first 
decision is how to diagnose the disorder since the patient 
is rarely aware that he/she suffers from it. On the other 
hand, it is unrealistic for the family doctor to observe pa-
tients at work and, even if it were possible to do so, the 
chances of diagnosing burnout during a doctor’s visit 
would be next to none since people perform differently 
when observed at work. They do not seek help until burn-
out begins influencing their work performance so badly 
that their employment may be in jeopardy. 
Table 1. Symptoms commonly found in burnout, mood and anxiety disorders
Symptoms
Major 
depressive 
disorder
Generalized 
anxiety 
disorder
Post-
traumatic 
stress disorder
Acute stress 
disorder Burnout
Depressed mood char c c s
Loss of interest or pleasure char c c
Demoralization / subjective incompetence c char
Anxiety c char char char c
Derealization char char c
Depersonalization char char c
Changes in appetite or weight c c c c c
Insomnia or hypersomnia c c c c c
Psychomotor agitation or retardation c m m c
Fatigue or loss of energy c c c c char
Feelings of worthlessness, excessive or inappropriate guilt c c c
Diminished ability to think or concentrate, or indecisiveness c c c c c
Memory impairment c c d d c
Recurrent thoughts of death, suicidal ideation, or suicide 
attempt 
c c c
Significant impairment in social, occupational, and other 
important areas of functioning.
c c c c
Somatic complaints c t c c
Autonomic hyperarousal and exaggerated startle response l c c c
Increased irritability c c c char
char – characteristic; c – common; s – sometimes present; m – motor restlessness; d – dissociative amnesia; 
t – muscle tension; l – less prominent.
Based on DSM-IV-TR diagnostic criteria for mood and anxiety disorders and the following references: 2, 9, 11, 20, 21, 23, 42–46.
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case of a “worn-out” subtype, a person essentially “gives 
up”. When confronted with too much stress or too little 
gratification, a person with a worn­out subtype becomes 
apathetic and lacks enthusiasm. In the “classic” burnout, 
a person works to the point of exhaustion. However, it is 
itself insufficient for burnout to occur. In the “under chal-
lenged” subtype of burnout, a person is negatively affected 
by monotonous work. Farber criticized viewing burnout as 
a single phenomenon and stated that different types of 
burnout may require different forms of treatment [14]. 
Meanwhile, Montero-Marín et al. [15] made an attempt 
to define and systematize the properties that characterize 
Farber’s typology proposal. The classification criterion for 
this systematized typology is based on the level of dedi-
cation at work: high in “frenetic” subjects (active coping 
style), intermediate in “under-challenged” workers and 
low in “worn-out” subjects (passive coping style). The 
“frenetic” burnout subtype is characterized by the invest-
ment of a large amount of time in work and is common 
in highly-involved, ambitious and overloaded individuals. 
The “under­challenged” burnout subtype is influenced 
by the occupation type. It appears in indifferent and 
bored individuals who do not find a chance for personal 
Burnout is more common than generally believed. The 
frequency of high scores in at least one of the three dimen-
sions of the MBI was 70.14% [12]. The selected partici-
pants were 67 on-call physicians at ICUs in Maceió, Brazil. 
Burnout was diagnosed when high scores were observed 
in at least one of the three dimensions. The frequency of 
high scores in all three dimensions of the MBI together 
was 17.91%, while the frequencies of a high score in each 
of the three dimensions analyzed separately were 41.79% 
for emotional exhaustion, 37.31% for depersonalization, 
and 58.2% for inefficiency. 
Managing burnout
Although the treatment and prevention of occupational 
burnout primarily lie in the implementation of proper or-
ganizational changes, developing proper coping skills is an 
essential element of prevention and treatment. Choosing 
the most effective approach depends on our knowledge of 
burnout types and their dynamics.
Determining the type of burnout is important since it con-
ditions the type of treatment. Farber [13] proposed three 
types of burnout: a “worn-out” subtype, a classic (fre-
netic) subtype, and an under-challenged subtype. In the 
Based on references: 15, 52 (with permission of J. Montero-Marín).
Fig. 1. Structure of systematized typology of under-challenged 
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Medical treatment of burnout
Medical treatment of burnout is mostly symptomatic: it in-
volves measures to prevent and treat the symptoms. Since 
symptoms vary in their degree of severity from person to 
person, there is an individual approach in developing an 
intervention treatment plan that targets the occurring 
symptoms as well as the accompanying disorders such as 
anxiety, restlessness, headaches, sleep disturbances, prob-
lems associated with concentrating, constant feeling of fa-
tigue, irritability, major depression, increased sensitivity to 
pain, susceptibility to infections, muscle tension, dizziness, 
gastrointestinal disorders, hypertension, cardiovascular 
problems and other disorders. 
Symptoms of stress can be relieved temporarily with 
drugs, although they do not remove the cause of stress. 
The therapeutic benefit of anxiolytics and sedatives is 
well-established. Anxiolytics and sedatives induce seda-
tion by reducing irritability and psychomotor agitation. 
Benzodiazepines and barbiturates potentiate gamma-ami-
nobutyric acid (GABA), which produces calming effects 
and is the most important inhibitory neurotransmitter in 
the central nervous system (CNS).
Anxiolytics are prescribed when the expected benefits of 
the treatment outweigh the potential hazards. The major 
concern is the risk of developing an addiction. People who 
have difficulty dealing with stress, anxiety or sleep disor-
ders may overuse or become dependent on sedatives. Ben-
zodiazepines and other anxiolytics, even at therapeutic 
doses, can lead to dependence after only a brief period of 
use [17]. There are also serious paradoxical reactions that 
may occur in conjunction with the use of sedatives that 
result in unexpected outcomes in some individuals. Lader 
and Morton [18] estimated the incidents of these adverse 
reactions to be about 5%, even in case of short-term use. 
The paradoxical reactions may consist of depression, with 
or without suicidal tendencies, phobias, violent behavior 
and symptoms sometimes misdiagnosed as psychosis [19]. 
Anxiolytics sometimes cause memory loss (i.e. amnesia). 
development in their work. The “worn-out” burnout sub-
type is determined by the rigidity of the organizational 
structure of an individual’s workplace and is characterized 
by the lack of control over results, lack of recognition for 
efforts and neglecting responsibilities [16]. This is illus-
trated by Fi gure 1. 
According to Farber [14], “Psychoanalytic insight, cogni-
tive restructuring, empathic concern, and stress-reduction 
techniques may all be necessary, albeit in different com-
binations, to successfully treat the burnout of each type”. 
The “worn-out” teachers manifested symptoms similar to 
depression, including a perceived loss of self-esteem [14]. 
According to Farber [14], this type of burnout often re-
quires cognitive approaches that aim to rebalance his 
or her perceptions. By contrast, a classically burned-out 
teacher is often helped by a more psychodynamic ap-
proach that focuses on the person’s strong need for great 
achievement. In the “under-challenged” type of burnout, 
teachers could benefit from assertiveness training [14]. 
Further research is needed to determine the most effec-
tive therapy approach in different types of burnout.
In time, family physicians ought to be aware of such classi-
fication and refer the patient to a psychiatrist, who should 
be able to classify burnout correctly: this will be the second 
most important medical decision to be made. We recom-
mend the use of the “Burnout Clinical Subtype Question-
naire” (BCSQ), in its extended version or the BCSQ-36, or 
its short version, or the BCSQ-12, introduced by Montero-
Marín. It is the first clinical burnout scale introduced by 
psychiatrists that makes it possible to establish the burn-
out type. Empirical evidence was provided for the content 
validity, and relationships with relevant sociodemographic 
and laboral variables were described [15,16].
The classical Maslach description of burnout does not in-
clude the frenetic profile. The Burnout Clinical Subtype 
Questionnaire is quite a useful tool for the evaluation and 
choosing specific treatment strategies based on the type 
of burnout. 
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or in higher doses when depression is present [22]. There-
fore, antidepressants are considered as the last resort in 
treating insomnia in burnout after the administration of 
standard hypnotics. 
Controversies
The use of antidepressants for treating burnout remains 
controversial. Often, antidepressants are prescribed by 
family doctors without taking into account patients’ speci-
fic physiological profiles. One of the reasons of prescribing 
antidepressants to burnout patients is their sedative effect. 
According to a study conducted at the Finnish Institute of 
Occupational Health in Helsinki, Finland, antidepressants 
comprised the most commonly used drug group, especial-
ly among employees with severe burnout [23]. This study 
used data from a nationally representative Finnish sample 
of 3276 employees, aged from 30 to 64 years. Research-
ers in this study pointed out that the use of antidepres-
sant medication did not seem to be fully explained by the 
pre sence of a depressive or anxiety disorder among the 
employees with severe burnout. Those with severe burn-
out were given antidepressants, anxiolytics, and hypnotics 
more often than those without burnout. 
In this study, burnout was measured using the Maslach 
Burnout Inventory-General Survey (MBI-GS) [11]. The 
items were scored on a seven-point frequency rating 
scale ranging from 0 (never) to 6 (daily). High scores 
for exhaustion and cynicism and low scores for profes-
sional efficacy are indicative of burnout. The items of 
professional efficacy were reversed (lack of profession-
al efficacy). To assess the level of burnout, researchers 
calculated the weighted total score of the dimensional 
scores so that exhaustion, cynicism, and lack of profes-
sional efficacy had different weights in the syndrome 
(0.4 × exhaustion +0.3 × cynicism +0.3 × lack of pro-
fessional efficacy). Burnout and the dimensional scores 
were categorized as follows: no burnout (scores: 0–1.49), 
mild burnout (scores: 1.50–3.49), and severe burnout 
Lorazepam is one such pharmacological agent that can 
cause anterograde amnesia. Physicians need to consider 
the long-term side effects of any psychotropic drug. Me-
mory impairment itself could lead in future to decreased 
work performance and therefore is a risk factor for 
burnout. 
Burnout is characterized by impaired sleep. Stress dis-
rupts the circadian rhythmic secretion of cortisol. The 
circadian rhythm of hormones and mental performance 
were investigated in male cadets during a five­day military 
training course with continuous heavy physical activities 
and with almost total lack of food and sleep [20]. The 24-h 
means for androstenedione, dihydroepiandrosterone 
(DHEA), 17 alpha-hydroxyprogesterone, testosterone 
and thyroid-stimulating hormone decreased strongly dur-
ing the course, and the circadian rhythm was reduced to 
below the minimum levels measured during the control 
tests. Mental performance also decreased. It is therefore 
suggested that impaired sleep may play a role in the deve-
lopment of fatigue in burnout [21].
When insomnia interferes with daytime functioning, 
a short-term treatment with hypnotics is recommended. 
Hypnotics ought to be prescribed in the lowest effec-
tive dosage for a short period of time. If there is a need 
for a long term treatment, intermittent therapy should be 
recom mended [22]. Prolonged use is discouraged because 
tolerance can develop. The optimal treatment is to combine 
hypnotics with Cognitive Behavior Therapy (CBT) [22]. 
Cognitive­behavioral strategies are more difficult to imple-
ment and take longer, but the effects are longer lasting, up 
to two years after the treatment has ended. These strategies 
include sleep hygiene, education, relaxation training, stimu-
lus control, and cognitive therapy [22].
Low doses of some antidepressants at bedtime may im-
prove sleep, e.g. doxepin 25 to 50 mg, paroxetine 5 to 20 mg, 
trazodone 50 mg, trimipramine 75 to 200 mg [22]. How-
ever, antidepressants should be used in these low doses 
mainly when standard hypnotics are not tolerated (rare) 
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Burnout symptoms are significantly related to endocrine 
functioning. Severe burnout symptoms are associated with 
a lower level or smaller increase of the cortisol awaken-
ing response (CAR), higher dehydroepiandrosterone-sul-
phate (DHEAS) levels, lower cortisol/DHEAS ratios and 
stronger suppression as measured by the dexamethasone 
suppression test (DST). Such results support the view that 
burnout symptoms are associated with HPA-axis function-
ing (Tables 2 and 3). 
Antidepressants directly increase the expression and 
function of corticosteroid receptors in the brain, thus 
enhance the negative-feedback and reduce the HPA axis 
activity. They also directly increase the intracellular con-
centrations of cortisol, but not of corticosterone [26,27]. 
In addition to this, they directly inhibit membrane steroid 
transporters that expel glucocorticoids out of the cells. 
By blocking these transporters, antidepressants increase 
the intracellular levels of glucocorticoids. The findings 
also support the role of steroid transporters in the effects 
of antidepressants on GR function [26,27]. The authors 
demonstrated that coincubation of antidepressants and 
glucocorticoids leads to increased GR function if the glu-
cocorticoids are a substrate for the transporters (dexa-
methasone and cortisol). Decreased GR function was 
also observed when glucocorticoid was not a substrate 
for the transporters (corticosterone). It is essential to 
know the mechanisms of action of antidepressants and 
(scores: 3.50–6). According to this categorization, in 
severe burnout, the symptoms were experienced ap-
proximately daily or weekly, in mild burnout, they oc-
curred monthly, and in the case of no burnout, they were 
experien ced only a few times a year or never [23].
Another important finding in this study was that employ-
ees with burnout were less often the targets of occupa-
tional interventions than those without burnout, despite 
the emphasis on work conditions in the etiology of burn-
out. These findings demonstrate that the current situa-
tion in the prevention and treatment of burnout is not 
optimal. 
Although burnout and depression have similar symptoms, 
there are substantial differences on the physiological level. 
It was shown that emotional stress can lead to an elevated 
plasma level of norepinephrine, cortisol and free fatty 
acids [24]. During acute stress, the plasma cortisol levels 
rise, but during chronic stress, cortisol levels decline, lead-
ing to the state of depletion. 
Table 2. Laboratory findings in burnout, mood and anxiety disorders
Laboratory test
Major 
depressive 
disorder
Generalized 
anxiety disorder
Post-traumatic 
stress disorder
Acute stress 
disorder Burnout
Morning plasma cortisol ↑ ↑ ↓ ↑ ↓
Adrenocorticotropic hormone (ACTH) ↑ n or ↓ n or ↓
Dehydroepiandrosterone sulphate (DHEA-S) ↓ ↓ or ↑ ↑ ↑
n – normal levels.
↑ – increased levels.
↓ – decreased levels.
Based on references: 7, 8, 24, 25, 42, 46–50. 
Table 3. A low-dose dexamethasone suppression test in 
burnout vs. mood and anxiety disorders
Condition/disorder Dexamethasone  suppression test
Burnout hypersuppression of cortisol
Major depressive disorder no suppression of cortisol
Posttraumatic stress disorder hypersuppression of cortisol
Based on references: 42, 47, 49, 51.
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of novel selective steroids for the treatment of stress-re-
lated disorders.
Some clinicians use very low doses of cortisol (1.25–2.5 mg/
day) in patients with a low plasma cortisol level [29]. Re-
search indicates that the best course of action is first to 
evaluate and treat hormonal deficiencies with hormones 
prior to prescribing psychotropic medications [30]. Some 
serotonin reuptake inhibitors (SSRIs) such as paroxetine 
and sertraline could increase cortisol levels in some de-
pressed patients [31]. 
An in-patient study was conducted to compare the effects 
of 10 mg and 30 mg doses of intravenous naloxone and 
nalmefene in healthy volunteers [32]. Significant increases 
in ACTH and cortisol levels were observed after both an-
tagonists, without an apparent dose-response relationship. 
Almefene injection resulted in greater HPA axis activation 
than either dose of naloxone. Researchers suggest that 
kappa- and delta-opioids may play important roles in the 
regulation of the HPA axis. Nalmefene may be useful as 
a pharmacotherapeutic agent for HPA-axis regulation. 
Opioid antagonists activate the HPA-axis. They may have 
a desirable effect in severe burnout patients when the HPA-
axis is hypofunctioning. In this study, increased HPA-axis ac-
tivity was observed in healthy volunteers. It is hard to predict 
whether opioid antagonists will be as effective in burnout 
patients as in healthy individuals. Future studies are needed 
to determine the effects of opioid antagonists in burnout. 
On the other hand, the activation of opioid receptors de-
creases HPA-axis activity. Endogenous opioid peptides 
(POMC, beta-endorphin, enkephalins and dynorphins) and 
the endocannabinoid system (ECS; anandamide, 2-arachi-
donoylglycerol) also regulate the HPA-axis. Considering 
the current knowledge on possible pathomechanisms of the 
burnout syndrome, the activation of opioid and cannabinoid 
receptors is promising in burnout prevention and treatment 
since it improves the mood and enhances the ability to cope 
with stress. The endocannabinoid system (eCB) has been 
found to control the neurotransmitter release from se veral 
their potential effects on patients with depression and 
burnout.
According to the new research at the Center for Studies 
on Human Stress at the Lafontaine Hospital in Mon-
treal [24], antidepressants, having the effect of lowering 
the cortisol levels, could reduce these levels in burnout 
patients even more and potentially put them at a higher 
risk of spiralling into burnout. The researches opt for the 
development of evidence-based approaches and technolo-
gies that distinguish burnout from depression. The same 
researchers suggest that it would be important for physi-
cians and psychiatrists to do a series of cortisol tests. Re-
ally high or really low cortisol levels are warnings of po-
tential burnout and also the risk of mental health issues 
in general. The saliva cortisol test could help employees 
realize they need to amend their lives to reduce their 
stress, and also help doctors steer the patients at risk into 
stress reduction programs. The researchers mentioned 
above also suggest that testing saliva for cortisol could be 
useful in predicting burnout and it could help people with 
symptoms of burnout avoid being put on medication that 
might actually make the condition worse. Research about 
the possible relationships between the subtypes of burn-
out and psychophysiological variables, such as the levels 
of cortisol, could be quite helpful in choosing the most ap-
propriate treatment for each particular subtype.
Developing new treatment approaches
The influence of cortisol on brain functioning and its role 
in glucocorticoid feedback is commonly accepted. The 
penetration of cortisol in the human brain is less extensive 
than that of corticosterone [28]. The ratio of corticoste-
rone over cortisol in the brain was significantly increased 
comparably to plasma. The research suggests that corti-
costerone has a more prominent role in human brain func-
tioning than had previously been recognized. The prefe-
rential uptake of corticosterone in the human brain over 
cortisol in stress disorders could lead toward development 
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concentration and increased the cortisol/cortisone ratio. Dai-
ly doses of 1.5 g can constantly inhibit 11 beta OHSD.
Another study [39] proposed that an acceptable daily in-
take of glycyrrhizin is 0.015–0.229 mg glycyrrhizin/kg body 
weight per day, based on in vivo and clinical evidence. The 
researchers report that licorice root extracts can be used 
to maintain cortisol levels, when taken in smaller doses, 
and that severe hypocortisolism may require three or four 
separate doses throughout the day.
A number of supplements have traditionally been used as 
sedatives, such as L-theanine, Passiflora incarnata, Valeri-
ana officinalis, Humulus lupulus, Matricaria chamomilla, 
Galphimia glauca, Bacopa monniera, Centella asiatica, 
Melissa officinalis, Piper methysticum, Scutellaria lateriflora, 
and Ziziphus jujuba [40]. 
Numerous botanicals have been listed as “adaptogens”. 
An adaptogenic herb is defined as a substance that increas-
es the body’s ability to resist stress and exerts a ba lancing ef-
fect on various systems of the body such as the immune, cen-
tral nervous and cardiovascular systems. Adaptogens under 
this definition include Eleutherococcus senticosus (Siberian 
Ginseng), Panax Ginseng, Rhodiola rosea, Schisandra chin-
ensis, Withania somnifera (Ashwaghanda), Astragalus mem-
branaceus, Scutellaria baicalensis and others. Panossian and 
Wikman [41] suggest that “adaptogenic herbs work by in-
ducing specific heat­shock proteins within cells, which pro-
tects both cells and organs during stress-induced changes 
in homeostasis”. Further research studies are required to 
determine the efficacy of the supplements in humans and 
especially in burnout patients.
CONCLUSION
Evidently, today’s medicine has not yet developed suf-
ficient methods for treating medical burnout, although 
it is possible to categorize the burnout problem accord-
ing to previous studies. There is no doubt that acute and 
chronic stress affects human health and the mortality rate. 
neuron populations (e.g. GABA, glutamate, catecho lamines 
and monoamines), suggesting a general mechanism for tun-
ing neuronal activity, and thereby regulating the responses 
to emotion and stress. 
Activating the eCB has been suggested by targeting endo-
cannabinoid-degrading enzymes to prolong the precisely 
regulated pro-homeostatic action of endocannabinoids 
[33]. Regulation of the endocannabinoid levels presents 
an opportunity to examine its effects in burnout preven-
tion and treatment. 
Dietary supplementation
When addressing burnout in patient rehabilitation, a state 
of depletion needs to be taken into account. Vitamins and 
minerals are crucial in addressing adrenal and HPA axis 
dysfunction. Cortisol synthesis is dependent on adequate 
supplies of various vitamins and minerals. The serum 
levels of calcium, potassium, zinc, iron and copper are 
reduced under cortisol secretion. Vitamin C, Niacin de-
rivatives, pantothenic acid and folic acid are important to 
maintain steroid secretion from the adrenal cortex [34]. 
Supplementation with omega-3 fatty acids inhibits the ad-
renal activation elicited by mental stress [35]. After three 
weeks of fish oil supplementation, the cortisol spike fol-
lowing a stress test was abolished and the epinephrine 
spike was significantly blunted [36]. The norepinephrine 
concentration was significantly decreased in the experi-
mental group with docosahexaenoic acid (DHA) intake, 
whereas its levels did not change in the control group [37]. 
Research suggests that these effects of DHA intake may 
be applied to people under psychological stress.
Krähenbühl et al. [38] examined the inhibitory effects of 18 
beta-Glycyrrhetinic acid (GRA) on 11 beta-hydroxysteroid 
dehydrogenase (11 beta OHSD), the enzyme responsible for 
conversion of cortisol to inactive cortisone. GRA is a major 
metabolite of glycyrrhizic acid (gly cyrrhizin), an important 
constituent of licorice and licorice root. In vivo, increas-
ing doses of GRA were associated with reduced cortisone 
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